Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Available from: http://www.eurosurveillance.org / ViewArticle.aspx?ArticleId=21169


In this issue


Home Eurosurveillance Edition  2008: Volume 13/ Issue 17 Article 1
Back to Table of Contents
Download (pdf)
Next

Eurosurveillance, Volume 13, Issue 17, 24 April 2008
Editorials
Tick-borne encephalitis: rounding out the picture
  1. Institute of Virology, Medical University of Vienna, Vienna, Austria

Citation style for this article: Heinz F. Tick-borne encephalitis: rounding out the picture. Euro Surveill. 2008;13(17):pii=18844. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18844
Date of submission: 21 April 2008

What is now known as tick-borne encephalitis (TBE) was first recognised as a distinct disease entity in 1931 in Europe by H. Schneider and described as 'meningitis serosa epidemica' of unknown etiology [1]. A disease with similar clinical symptoms was reported in the Far East in 1934 and briefly thereafter ­– in 1937 – the etiologic agent was isolated in Russia and its transmission by ticks could also be demonstrated [2]. In Finland, TBE was initially described as 'Kumlinge disease' in the 1940s [3] and the first European TBE virus was isolated in Czechoslovakia during an epidemic in 1948 [4].

Since those historic days, the scientific development in the area of TBE and flaviviruses in general has been enormous. Today, we are experiencing an explosion of new information, both on the structure and molecular biology of these viruses and the biological principles underlying their natural cycles [5]. It is especially pleasing to see that the purified inactivated vaccine available on the market [6] has an excellent profile of field effectiveness as well as safety, and vaccination therefore proved to be an extremely successful measure for preventing disease [7].

Nevertheless, there are several aspects in the context of TBE that have not yet been satisfactorily dealt with, including the question of different clinical disease pictures induced by the three TBE virus subtypes (European, Siberian, and Far Eastern), the lack of standardisation of case definitions, laboratory diagnosis, reporting and documentation of the disease as well as of endemic areas. The latter issue, of course, relates to possible changes of the distribution of natural TBE virus foci because of climatic changes, and we are only at an early stage of understanding in which way complex biological systems control the maintenance of the virus in nature [5,8].

A critical review of the present surveillance systems for TBE in different European countries – as presented in this issue’s article by O Donoso Mantke et al [9] – is therefore most welcome, and pinpoints those areas that need to be addressed in further activities of investigation.


References

  1. Schneider H. Über epidemische Meningitis serosa. Wien Klin Wschr. 44:350 (1931).
  2. Smorodintsev AA. Tick-borne spring-summer encephalitis. Prog Med Virol. 1958;1:210-47.
  3. Wahlberg P, Saikku P, Brummer-Korvenkontio M. Tick-borne viral encephalitis in Finland. The clinical features of Kumlinge disease during 1959-1987. J Intern Med. 1989; 225(3):173-7.
  4. Gallia F, Rampas J, Hollender J. Laboratori infekce encefalitickym virem. Cas.Lek.Ces. 1949;88:225.
  5. Randolph SE, Green RM, Peacy MF, Rogers DJ. Seasonal synchrony: the key to tick-borne encephalitis foci identified by satellite data. Parasitology. 2000 Jul;121 (Pt 1):15-23.
  6. Barrett PN, Dorner F, Ehrlich H, et al. Tick-borne encephalitis virus vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia: Saunders; 2004:1039-55.
  7. Heinz FX, Holzmann H, Essl A, Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine. 2007 Oct 23;25(43):7559-67.
  8. Nuttall PA, Labuda M. Dynamics of infection in tick-vectors and at the tick-host interface. Adv Virus Res. 2003;60:233-72.
  9. Donoso Mantke O, Schädler R, Niedrig M. A survey on cases of tick-borne encephalitis in European countries. Euro Surveill. 2008;13(17):pii=18848. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18848

 



Back to Table of Contents
Download (pdf)
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.